Xponance, Inc. United Therapeutics Corp Transaction History

Xponance, Inc.

$10.7 Billion
Q4 2024

A detailed history of Xponance, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Xponance, Inc. holds 7,350 shares of UTHR stock, worth $2.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,350

Previous 6,745 8.97%

Holding current value

$2.6 Million

Previous $2.42 Million 7.28%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$348.66 - $410.0 $210,939 - $248,050	605 Added 8.97%	7,350 $2.59 Million
Q3 2024 Nov 12, 2024	SELL	$311.04 - $363.55 $41,679 - $48,715	-134 Reduced 1.95%	6,745 $2.42 Million
Q2 2024 Aug 14, 2024	SELL	$228.26 - $319.04 $191,281 - $267,355	-838 Reduced 10.86%	6,879 $2.19 Million
Q1 2024 May 13, 2024	BUY	$210.76 - $249.51 $445,968 - $527,963	2,116 Added 37.78%	7,717 $1.77 Million
Q4 2023 Jan 31, 2024	BUY	$214.88 - $256.94 $1,504 - $1,798	7 Added 0.13%	5,601 $1.23 Million
Q3 2023 Oct 23, 2023	SELL	$211.82 - $248.24 $22,241 - $26,065	-105 Reduced 1.84%	5,594 $1.26 Million
Q2 2023 Jul 13, 2023	SELL	$205.19 - $232.99 $83,512 - $94,826	-407 Reduced 6.67%	5,699 $1.26 Million
Q1 2023 Apr 17, 2023	BUY	$212.99 - $276.17 $15,548 - $20,160	73 Added 1.21%	6,106 $1.37 Million
Q4 2022 Jan 23, 2023	BUY	$205.95 - $280.43 $128,100 - $174,427	622 Added 11.5%	6,033 $0
Q3 2022 Oct 24, 2022	SELL	$203.3 - $244.17 $5,489 - $6,592	-27 Reduced 0.5%	5,411 $1.13 Million
Q2 2022 Aug 02, 2022	BUY	$174.81 - $241.14 $69,749 - $96,214	399 Added 7.92%	5,438 $1.28 Million
Q1 2022 Apr 20, 2022	SELL	$166.16 - $213.96 $2,990 - $3,851	-18 Reduced 0.36%	5,039 $904,000
Q4 2021 Jan 31, 2022	SELL	$184.32 - $216.08 $10,690 - $12,532	-58 Reduced 1.13%	5,057 $1.09 Million
Q3 2021 Nov 05, 2021	SELL	$179.86 - $214.88 $31,295 - $37,389	-174 Reduced 3.29%	5,115 $944,000
Q2 2021 Aug 12, 2021	BUY	$170.47 - $211.93 $95,292 - $118,468	559 Added 11.82%	5,289 $949,000
Q1 2021 May 10, 2021	BUY	$153.94 - $174.85 $615 - $699	4 Added 0.08%	4,730 $791,000
Q4 2020 Feb 11, 2021	BUY	$101.87 - $151.79 $101 - $151	1 Added 0.02%	4,726 $717,000
Q3 2020 Oct 26, 2020	BUY	$99.9 - $121.13 $69,530 - $84,306	696 Added 17.27%	4,725 $477,000
Q2 2020 Aug 14, 2020	BUY	$92.74 - $125.82 $373,649 - $506,928	4,029 New	4,029 $488,000

Others Institutions Holding UTHR

# of Institutions

696

Shares Held

60.8M

Call Options Held

194K

Put Options Held

292K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.1B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account